Zeroing in on Xylazine

Sponsor: Boston Medical Center Grayken Center for Addiction TTA, Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS) Description This training will provide knowledge regarding xylazine, a CNS depressant, which has been linked to an increasing number of overdose deaths in the US. This training will discuss the physiologic effects of xylazine, manifestations of xylazine intoxication, overdose, communicable infections associated with xylazine use, and wound care for persons injecting xylazine. Intended audience Intended audience: Providers,… Read more »

Xylazine and HIV in the Era of Synthetic Street Drugs

Sponsor: National Alliance for HIV Education and Workforce Development This session is part of NAHEWD’s national webinar series Bridging HIV and SUD: Innovations in the Field. The series will highlight various innovative models and approaches to treating substance use disorder (SUD) in people at risk for and living with HIV. This presentation will review the history of US street drug markets since the early 1990s to explain the emergence of xylazine, fentanyl, and crystal methamphetamine… Read more »

New Substances of Abuse

Sponsor: NH Alcohol & Drug Abuse Counselors Association This training is designed for clinicians at any skill level to explore and understand the changing nature of chemicals of addiction. New substances of abuse are being created, changed, marketed and promoted to us every day. We are inundated with new kinds of drugs, both prescription and illicit and new combinations that are making headlines. Fentanyl is causing a surge in overdoses and fatalities and newer and… Read more »

Effective Group Treatment: Leveraging CBT and MI in Telehealth Groups

Sponsor: NH Alcohol & Drug Abuse Counselors Association Telehealth is proving to be sustainable and effective as treatment centers have transitioned traditional counseling services to online programs. Counselors are tasked to translate face to face skills to telehealth with limited training to recreate foundational helping. This presentation will provide counselors with the tools to create virtual counseling groups which can be applicable to various levels of care. Participants will obtain skills to enhance group cohesion… Read more »

Neurobiology of Addiction

Sponsor: NH Alcohol & Drug Abuse Counselors Association PRESENTATION:This training is designed to advance our understanding of the biological components of addiction. It addresses both chemical addictions and behavior addictions such as gambling and social media. It is appropriate for clinicians, preventions specialists and administrative staff. The most up to date research and information available will help us to not only understand addiction but inform our plans for recovery, and educate our clients. New chemicals… Read more »

The Evolution of Buprenorphine: Prescribing Practices and Efforts to Increase MOUD Access

Sponsor: The American Osteopathic Academy of Addiction Medicine This talk will describe the distribution of buprenorphine patient caseloads for clinicians prescribing formulations of buprenorphine indicated to treat opioid use disorder, how those caseloads evolve over time, and factors associated higher-volume buprenorphine prescribers. The presentation will also discuss implications for expanding access to medication treatment for opioid use disorder and state and federal policy efforts. At the conclusion of trhe seminar learners will be able to:… Read more »

Update on the U.S. Overdose Crisis: Which Drugs, Who is Dying, and How do we Save Lives?

Sponsor: The American Osteopathic Academy of Addiction Medicine In this talk, the presenter will review findings from national and local epidemiological studies on recent changes in U.S. overdose mortality. In recent years, overdose deaths increasingly involve polysubstance, namely opioids and stimulants. Fentanyl dominates almost everywhere, but the other specific drugs implicated vary regionally. Overdose rates are quickly rising among populations that previously had relatively low overdose mortality, including older adults, teens, Black people, and Hispanic/Latine… Read more »

Operationalizing a Definition of Precipitated Withdrawal and the Absorption, Distribution, Metabolism, and Elimination of Illicitly Manufactured Fentanyl

Sponsor: The American Osteopathic Academy of Addiction Medicine Kelly Dunn, PhD, MBA This webinar will discuss challenges of illicit fentanyl consumption. The data presented will discuss a recent operational definition of precipitated opioid withdrawal, drawn from an empirical study, and will introduce how the unique absorption, distribution, metabolization, and excretion of fentanyl may be contributing to fentanyl’s unique profile of effects in patients. Learning Objectives: At the conclusion of the seminar learners will be able… Read more »

Upcoming Community Rounds Workshop Series Session:Nurse Practitioners and Physician Assistants as Buprenorphine Providers: Facilitators and Barriers

Sponsor: Center on Rural Addiction University of Vermont This presentation will describe the expansion of nurse practitioners and other advanced practice clinicians into opioid use disorder treatment, particularly in rural communities. It will also explore barriers and facilitators regarding nurse practitioner engagement in buprenorphine treatment, including regulations, education, and broader social factors such as stigma. Specific considerations for advanced practice clinicians’ work with members of rural communities will be discussed. Register and attend to learn… Read more »

Xylazine and How it Harms People Who Use Drugs

Sponsor: Providers Clinical Support System Target Audience: This activity was developed to meet the needs of physicians and all interprofessional healthcare providers. Description: We will review what is known to date on Xylazine, a CNS depressant, which has been linked to an increasing number of overdose deaths in the US. This Roundtable will discuss its physiologic effects, and risk of xylazine harms including overdose and wounds along with suggested clinical best practices for providers and patients…. Read more »